InfraScan to Present at “Investment In Innovation (In3) WEST” Conference
Read more here
News
NuPathe Licenses Novel Drug Delivery Technology from University of Pennsylvania
Read more here
InfraScan Announces First Patients Enroll in Clinical Trial in Brain Hematoma Detection
Read more here
Picking the Brains of Venture Capitalists
Read more here
BioAdvance Invests In Midway Pharmaceuticals to Support Promising Development Program for GI Therapies
Read more here
Galleon Pharmaceuticals Named SR One Biotech Company Of The Year
Read more here
InfraScan to Present at Medtech Insight and Windhover Information’s “Investment In Innovation (In3) WEST” Conference
Read more here
BioAdvance News 2006
Read more here